Cargando…

Social Risk Adjustment of Quality Measures for Diabetes and Cardiovascular Disease in a Commercially Insured US Population

IMPORTANCE: Patients’ social risk factors may be associated with physician group performance on quality measures. OBJECTIVE: To examine the association of social risk with change in physician group performance on diabetes and cardiovascular disease (CVD) quality measures in a commercially insured po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Christina A., Gilstrap, Lauren G., Chernew, Michael E., McWilliams, J. Michael, Landon, Bruce E., Landrum, Mary Beth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450315/ https://www.ncbi.nlm.nih.gov/pubmed/30924891 http://dx.doi.org/10.1001/jamanetworkopen.2019.0838

Ejemplares similares

Using Consistently Low Performance to Identify Low-Quality Physician Groups
por: Nguyen, Christina A., et al.
Publicado: (2021)

Association Between Clinical Practice Group Adherence to Quality Measures and Adverse Outcomes Among Adult Patients With Diabetes
por: Gilstrap, Lauren G., et al.
Publicado: (2019)

Opportunities for Savings in Risk Arrangements for Oncologic Care
por: Landon, Bruce E., et al.
Publicado: (2023)

Consistency and Adequacy of Public and Commercial Health Insurance for US Children, 2016 to 2021
por: Daw, Jamie R., et al.
Publicado: (2023)

Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance
por: Cham, Stephanie, et al.
Publicado: (2022)

Trends in Disenrollment and Reenrollment Within US Commercial Health Insurance Plans, 2006-2018
por: Fang, Hanming, et al.
Publicado: (2022)

Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic
por: Whaley, Christopher M., et al.
Publicado: (2020)

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers
por: Lin, Dora H., et al.
Publicado: (2018)

Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US
por: Horný, Michal, et al.
Publicado: (2021)

Mental Health Service Utilization Rates Among Commercially Insured Adults in the US During the First Year of the COVID-19 Pandemic
por: McBain, Ryan K., et al.
Publicado: (2023)

Breadth and Exclusivity of Hospital and Physician Networks in US Insurance Markets
por: Graves, John A., et al.
Publicado: (2020)

Analysis of Consistency in Emergency Department Physician Variation in Propensity for Admission Across Patient Sociodemographic Groups
por: Khidir, Hazar, et al.
Publicado: (2021)

Assessment of Patient Attribution to Care From Medical Oncologists, Surgeons, or Radiation Oncologists After Newly Diagnosed Cancer
por: Gondi, Suhas, et al.
Publicado: (2021)

Medical Costs of Substance Use Disorders in the US Employer-Sponsored Insurance Population
por: Li, Mengyao, et al.
Publicado: (2023)

No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients
por: Pyenson, Bruce S., et al.
Publicado: (2019)

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
por: DiStefano, Michael J., et al.
Publicado: (2023)

Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017
por: Mikosz, Christina A., et al.
Publicado: (2020)

Health Insurance Coverage and Postpartum Outcomes in the US: A Systematic Review
por: Saldanha, Ian J., et al.
Publicado: (2023)

Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use
por: Streed, Carl G., et al.
Publicado: (2022)

Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose
por: Follman, Sarah, et al.
Publicado: (2019)

Health Insurance and Differences in Infant Mortality Rates in the US
por: Johnson, Desalyn L., et al.
Publicado: (2023)

Value-Based Insurance Design: A “Clinically Sensitive, Fiscally Responsible” Approach to Mitigate The Adverse Clinical Effects of High-Deductible Consumer-Directed Health Plans
por: Fendrick, A. Mark, et al.
Publicado: (2007)

Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma
por: Jazowski, Shelley A., et al.
Publicado: (2022)

Association Between Diagnosis Code Expansion and Changes in 30‐Day Risk‐Adjusted Outcomes for Cardiovascular Diseases
por: Gilstrap, Lauren, et al.
Publicado: (2021)

Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients
por: Kilaru, Austin S., et al.
Publicado: (2020)

One-Year Adverse Outcomes Among US Adults With Post–COVID-19 Condition vs Those Without COVID-19 in a Large Commercial Insurance Database
por: DeVries, Andrea, et al.
Publicado: (2023)

Risk of Operative and Nonoperative Interventions Up to 4 Years After Roux-en-Y Gastric Bypass vs Vertical Sleeve Gastrectomy in a Nationwide US Commercial Insurance Claims Database
por: Lewis, Kristina H., et al.
Publicado: (2019)

Assessment of Dentist Participation in Public Insurance Programs for Children in the US
por: Serban, Nicoleta, et al.
Publicado: (2022)

Cost of Public Health Insurance for US-Born and Immigrant Adults
por: Kaushal, Neeraj, et al.
Publicado: (2023)

Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
por: Wallace, Beth I., et al.
Publicado: (2021)

Association of Criminal Statutes for Opioid Use Disorder With Prevalence and Treatment Among Pregnant Women With Commercial Insurance in the United States
por: Gressler, Laura E., et al.
Publicado: (2019)

Analysis of a Commercial Insurance Policy to Deny Coverage for Emergency Department Visits With Nonemergent Diagnoses
por: Chou, Shih-Chuan, et al.
Publicado: (2018)

Patterns of Use of a Price Transparency Tool for Childbirth Among Pregnant Individuals With Commercial Insurance
por: Gourevitch, Rebecca A., et al.
Publicado: (2021)

Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
por: McCoy, Rozalina G., et al.
Publicado: (2021)

Trends in US Health Insurance Coverage During the COVID-19 Pandemic
por: Bundorf, M. Kate, et al.
Publicado: (2021)

Racial and Ethnic Disparities in Glycemic Control Among Insured US Adults
por: Zakaria, Nora I., et al.
Publicado: (2023)

Trends in Infertility Care Among Commercially Insured US Women During the COVID-19 Pandemic
por: Zhou, Beth, et al.
Publicado: (2021)

Association of National Expansion of Insurance Coverage of Medically Tailored Meals With Estimated Hospitalizations and Health Care Expenditures in the US
por: Hager, Kurt, et al.
Publicado: (2022)

Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US
por: Miloh, Tamir, et al.
Publicado: (2023)

Human Papillomavirus Vaccine Administration Trends Among Commercially Insured US Adults Aged 27-45 Years Before and After Advisory Committee on Immunization Practices Recommendation Change, 2007-2020
por: Suk, Ryan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_90ro9m3krf5u58e2o27lpr2m8j